• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血修饰白蛋白(IMA)、红细胞分布宽度(RDW)及脂蛋白(LP)在糖尿病合并冠心病患者中的表达及预后价值

The expression and prognostic value of ischemia modified albumin (IMA), red blood cell distribution width (RDW), and lipoprotein (LP) in patients with diabetes mellitus complicated with coronary heart disease.

作者信息

Xiang Lu, Zhang Min, Wu Hongying, Xie Dili

机构信息

Department of Geriatric Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China; Chinese Academy of Sciences, Sichuan Translational Medicine Research Hospital, Chengdu, China.

Chinese Academy of Sciences, Sichuan Translational Medicine Research Hospital, Chengdu, China; Department of Outpatients, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.

出版信息

Ann Palliat Med. 2021 Apr;10(4):4463-4471. doi: 10.21037/apm-21-425. Epub 2021 Apr 16.

DOI:10.21037/apm-21-425
PMID:33894715
Abstract

BACKGROUND

This study explored the levels and prognostic value of ischemia modified albumin (IMA), red blood cell distribution width (RDW), and lipoprotein (LP) in patients with diabetes melltus (DM) complicated withcoronary heart disease (CHD).

METHODS

A total of 95 patients with DM who were diagnosed and treatedfrom January 2018 to January 2019 were retrospectively analyzed. All included patients underwent percutaneous coronary intervention (PCI). Patients with DM complicated with CHDwere designated group A (n=61) and patients without CHD complications were designated group B (n=34). During the same period, 45 patients without DM who underwent physical examination in our hospital were included as a control group.The levels of IMA, LP, and RDW in the 3 groups of patients were compared. The study examined the occurrence of cardiovascular events after PCI treatment in patients with DM complicated with CHD, and the related risk factors were assessed using multivariate logistic regression analysis. Furthermore, the receiver operating characteristic (ROC) curve was used to analyze the value of IMA, LP, and RDW in predicting cardiovascular events in DM patients complicated with CHD.

RESULTS

The levels of IMA, LP, and RDW werehigher in groups A and B compared to the control group (P<0.05). In patients who experienced a cardiovascular event, the levels of IMA, LP, and RDW were higher than those observed in patients who did not experience a cardiovascular event (P<0.05). The area under the ROC curve of IMA, LP, RDW, and the combination of the three factors for the prediction of cardiovascular events were 0.910, 0.774, 0.846, and 0.995, respectively. The combined detection of the 3 factors showed the best predictive value.Patients with abnormal values in blood lipids, blood creatinine, IMA, LP, and RDW had a significantly poorer prognosis in terms of adverse cardiovascular events (P<0.05). The unconditional multivariate logistic regression model showed that abnormal levels of blood creatinine, IMA, LP, and RDW were independent risk factors for cardiovascular events in patients with DM complicated with CHD after PCI treatment (P<0.05).

CONCLUSIONS

The levels of IMA, RDW, and LP wereincreased in patients with DM complicated with CHD. Furthermore, abnormal levels of IMA, LP, and RDW are independent risk factors that affect cardiovascular events in these patients following PCI treatment. The combined detection of all three indicators may be an effective means to predict the prognosis of these patients.

摘要

背景

本研究探讨了缺血修饰白蛋白(IMA)、红细胞分布宽度(RDW)和脂蛋白(LP)在糖尿病(DM)合并冠心病(CHD)患者中的水平及预后价值。

方法

回顾性分析2018年1月至2019年1月期间诊断并接受治疗的95例DM患者。所有纳入患者均接受经皮冠状动脉介入治疗(PCI)。DM合并CHD患者被指定为A组(n = 61),无CHD并发症的患者被指定为B组(n = 34)。同期,将在我院接受体检的45例无DM患者纳入作为对照组。比较3组患者的IMA、LP和RDW水平。本研究考察了DM合并CHD患者PCI治疗后心血管事件的发生情况,并采用多因素logistic回归分析评估相关危险因素。此外,采用受试者工作特征(ROC)曲线分析IMA、LP和RDW在预测DM合并CHD患者心血管事件中的价值。

结果

A组和B组的IMA、LP和RDW水平均高于对照组(P < 0.05)。发生心血管事件的患者的IMA、LP和RDW水平高于未发生心血管事件的患者(P < 0.05)。IMA、LP、RDW以及三者联合预测心血管事件的ROC曲线下面积分别为0.910、0.774、0.846和0.995。三项指标联合检测显示出最佳预测价值。血脂、血肌酐、IMA、LP和RDW值异常的患者在不良心血管事件方面的预后明显较差(P < 0.05)。无条件多因素logistic回归模型显示,血肌酐、IMA、LP和RDW水平异常是DM合并CHD患者PCI治疗后心血管事件的独立危险因素(P < 0.05)。

结论

DM合并CHD患者的IMA、RDW和LP水平升高。此外,IMA、LP和RDW水平异常是影响这些患者PCI治疗后心血管事件的独立危险因素。三项指标联合检测可能是预测这些患者预后的有效手段。

相似文献

1
The expression and prognostic value of ischemia modified albumin (IMA), red blood cell distribution width (RDW), and lipoprotein (LP) in patients with diabetes mellitus complicated with coronary heart disease.缺血修饰白蛋白(IMA)、红细胞分布宽度(RDW)及脂蛋白(LP)在糖尿病合并冠心病患者中的表达及预后价值
Ann Palliat Med. 2021 Apr;10(4):4463-4471. doi: 10.21037/apm-21-425. Epub 2021 Apr 16.
2
The value of serum lipoprotein-associated phospholipase A2, ischemia-modified albumin, and cystatin C in predicting coronary heart disease risk: a single center retrospective cohort study.血清脂蛋白相关磷脂酶 A2、缺血修饰白蛋白和胱抑素 C 在预测冠心病风险中的价值:一项单中心回顾性队列研究。
Eur Rev Med Pharmacol Sci. 2023 Nov;27(21):10730-10735. doi: 10.26355/eurrev_202311_34353.
3
The Predictive Value of Red Cell Distribution Width and Red Cell Distribution Width to Erythrocyte Count Ratio for Adverse Cardiovascular Events During the Hospitalization of Patients of ST-segment Elevation Myocardial Infarction.红细胞分布宽度及红细胞分布宽度与红细胞计数比值对ST段抬高型心肌梗死患者住院期间不良心血管事件的预测价值
Clin Lab. 2020 Jul 1;66(7). doi: 10.7754/Clin.Lab.2019.191123.
4
Serum IMA and LP-PLA2 Levels in Patients with Coronary Heart Disease and Their Correlation with the Degree of Myocardial Ischaemia and Their Diagnostic Value.冠心病患者血清缺血修饰白蛋白和脂蛋白相关磷脂酶A2水平及其与心肌缺血程度的相关性和诊断价值
Emerg Med Int. 2022 Jun 11;2022:1698315. doi: 10.1155/2022/1698315. eCollection 2022.
5
Relationship between lipoprotein(a) and revascularization after percutaneous coronary intervention in type 2 diabetes mellitus patients with acute coronary syndrome.2型糖尿病合并急性冠脉综合征患者经皮冠状动脉介入治疗后脂蛋白(a)与血管重建的关系。
Curr Med Res Opin. 2022 Oct;38(10):1663-1672. doi: 10.1080/03007995.2022.2078080. Epub 2022 May 26.
6
Combined Value of Red Blood Cell Distribution Width and Global Registry of Acute Coronary Events Risk Score for Predicting Cardiovascular Events in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.红细胞分布宽度与急性冠状动脉事件全球注册风险评分联合预测行经皮冠状动脉介入治疗的急性冠状动脉综合征患者心血管事件的价值
PLoS One. 2015 Oct 15;10(10):e0140532. doi: 10.1371/journal.pone.0140532. eCollection 2015.
7
Red cell distribution width in coronary heart disease: prediction of restenosis and its relationship with inflammatory markers and lipids.红细胞分布宽度与冠心病:预测再狭窄及其与炎症标志物和脂质的关系。
Postgrad Med J. 2018 Sep;94(1115):489-494. doi: 10.1136/postgradmedj-2018-135806. Epub 2018 Oct 9.
8
Prognostic value of red blood cell distribution width-to-albumin ratio in ICU patients with coronary heart disease and diabetes mellitus.红细胞分布宽度与白蛋白比值对冠心病合并糖尿病 ICU 患者预后的价值。
Front Endocrinol (Lausanne). 2024 Sep 25;15:1359345. doi: 10.3389/fendo.2024.1359345. eCollection 2024.
9
Impact of Lipoprotein(a) on Long-term Outcomes in Patients With Diabetes Mellitus Who Underwent Percutaneous Coronary Intervention.脂蛋白(a)对接受经皮冠状动脉介入治疗的糖尿病患者长期预后的影响。
Am J Cardiol. 2016 Dec 15;118(12):1781-1785. doi: 10.1016/j.amjcard.2016.08.067. Epub 2016 Sep 13.
10
Application of neutrophil-lymphocyte ratio and red blood cell distribution width in diabetes mellitus complicated with heart failure.中性粒细胞与淋巴细胞比值及红细胞分布宽度在糖尿病合并心力衰竭中的应用
World J Diabetes. 2024 Jun 15;15(6):1226-1233. doi: 10.4239/wjd.v15.i6.1226.

引用本文的文献

1
Association between red cell distribution width/serum albumin ratio and Parkinson's disease.红细胞分布宽度/血清白蛋白比值与帕金森病之间的关联
Eur J Med Res. 2025 May 31;30(1):431. doi: 10.1186/s40001-025-02707-z.
2
Association between red blood cell distribution width and mortality in severe osteomyelitis patients.严重骨髓炎患者红细胞分布宽度与死亡率之间的关联
Sci Rep. 2025 Jan 2;15(1):360. doi: 10.1038/s41598-024-82891-w.
3
Prognostic value of red blood cell distribution width-to-albumin ratio in ICU patients with coronary heart disease and diabetes mellitus.
红细胞分布宽度与白蛋白比值对冠心病合并糖尿病 ICU 患者预后的价值。
Front Endocrinol (Lausanne). 2024 Sep 25;15:1359345. doi: 10.3389/fendo.2024.1359345. eCollection 2024.
4
A systematic review and meta-analysis of ischemia-modified albumin in diabetes mellitus.糖尿病中缺血修饰白蛋白的系统评价与荟萃分析。
Heliyon. 2024 Aug 10;10(16):e35953. doi: 10.1016/j.heliyon.2024.e35953. eCollection 2024 Aug 30.
5
Red blood cell distribution width is a useful biomarker to predict bleeding and thrombosis risks in patients with immune thrombocytopenic purpura.红细胞分布宽度是预测免疫性血小板减少性紫癜患者出血和血栓形成风险的有用生物标志物。
EJHaem. 2024 Apr 30;5(3):431-439. doi: 10.1002/jha2.897. eCollection 2024 Jun.
6
Utilizing red blood cell distribution width (RDW) as a reliable biomarker to predict treatment effects after chimeric antigen receptor T cell therapy.利用红细胞分布宽度(RDW)作为可靠的生物标志物来预测嵌合抗原受体 T 细胞治疗后的治疗效果。
Clin Exp Med. 2024 May 21;24(1):105. doi: 10.1007/s10238-024-01373-5.
7
Diagnostic values of ischemia modified albumin in diabetes-related complications: a narrative review.缺血修饰白蛋白在糖尿病相关并发症中的诊断价值:一项叙述性综述
J Diabetes Metab Disord. 2022 Nov 4;22(1):35-46. doi: 10.1007/s40200-022-01152-7. eCollection 2023 Jun.
8
Serum IMA and LP-PLA2 Levels in Patients with Coronary Heart Disease and Their Correlation with the Degree of Myocardial Ischaemia and Their Diagnostic Value.冠心病患者血清缺血修饰白蛋白和脂蛋白相关磷脂酶A2水平及其与心肌缺血程度的相关性和诊断价值
Emerg Med Int. 2022 Jun 11;2022:1698315. doi: 10.1155/2022/1698315. eCollection 2022.